# Exercise to Boost Response to Checkpoint Blockade Immunotherapy

> **NCT05358938** · EARLY_PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **H. Lee Moffitt Cancer Center and Research Institute** · enrollment: 22 (actual)

## Conditions studied

- Cutaneous Melanoma
- Cutaneous Squamous Cell Carcinoma
- Merkel Cell Carcinoma

## Interventions

- **OTHER:** Exercise
- **DRUG:** Checkpoint Blockade, Immune

## Key facts

- **NCT ID:** NCT05358938
- **Lead sponsor:** H. Lee Moffitt Cancer Center and Research Institute
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-06-21
- **Primary completion:** 2024-10-06
- **Final completion:** 2026-08
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2026-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05358938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05358938, "Exercise to Boost Response to Checkpoint Blockade Immunotherapy". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT05358938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*